{"nct_id":"NCT04178967","title":"Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis","status":"COMPLETED","status_verified_date":"2023-04","start_date":"2019-10-29","start_date_type":"ACTUAL","primary_completion_date":"2021-07-12","primary_completion_date_type":"ACTUAL","completion_date":"2022-04-28","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["LLY"]}